Vitamin D Supplementation in Acne
Not Applicable
Recruiting
- Conditions
- Acne Vulgaris
- Interventions
- Registration Number
- NCT06141330
- Lead Sponsor
- HITEC-Institute of Medical Sciences
- Brief Summary
The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is:
• To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone.
Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid.
Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
- Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included.
Exclusion Criteria
- Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs)
- Those with obesity
- Individuals employing vitamin supplementation
- Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Adapalene - Vitamin D Azithromycin 250 milligram Oral Capsule - Vitamin D D Max Drops - Placebo Azithromycin 250 milligram Oral Capsule - Vitamin D Adapalene -
- Primary Outcome Measures
Name Time Method Efficacious 2 months Improvement in Global Acne Grading System Score from baseline to after 2 months of treatment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hitec-Ims
🇵🇰Islamabad, Punjab, Pakistan